An Improved Synthesis of Resorcylic
Acid Macrolactone Inhibitors of Hsp90

James E. H. Day; Alexander J. Blake; Christopher J. Moody

doi:10.1055/s-0029-1217329

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2009(10): 1567-1570
DOI: 10.1055/s-0029-1217329

LETTER

An Improved Synthesis of Resorcylic Acid Macrolactone Inhibitors of Hsp90

James E. H. Day, Alexander J. Blake, Christopher J. Moody*
School of Chemistry, University of Nottingham, University Park, Nottingham, NG7 2RD, UK
Fax: +44(115)9513564; e-Mail: c.j.moody@nottingham.ac.uk;

Further Information

Publication History

Received 23 March 2009
Publication Date:
02 June 2009 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

A synthesis of resorcylic acid macrolactone analogues of the natural product radicicol is described in which the key steps are the acylation and ring opening of a homophthalic anhydride to give an isocoumarin, followed by a ring-closing metathesis to form the macrocycle.

Key words

macrocyclic lactones - isocoumarins - ring-closing metathesis reaction

References and Notes

1 Pearl LH. Prodromou C. Annu. Rev. Biochem. 2006, 75: 271

Crossref Google Scholar
2 Pearl LH. Prodromou C. Workman P. Biochem. J. 2008, 410: 439

Crossref Google Scholar
3 Workman P. Cancer Lett. 2004, 206: 149

Crossref Google Scholar
4 Hanahan D. Weinberg RA. Cell 2000, 100: 57

Crossref PubMed Google Scholar
5 Powers MV. Workman P. FEBS Lett. 2007, 581: 3758

Crossref Google Scholar
6 Bishop SC. Burlison JA. Blagg BSJ. Curr. Cancer Drug Targets 2007, 7: 369

Crossref Google Scholar
7 Solit DB. Chiosis G. Drug Discovery Today 2008, 13: 38

Crossref Google Scholar
8 Taldone T. Gozman A. Maharaj R. Chiosis G. Curr. Opin. Pharm. 2008, 8: 370

Crossref Google Scholar
9 Drysdale MJ. Brough PA. Curr. Top. Med. Chem. 2008, 8: 859

Crossref Google Scholar
10 Taldone T. Sun W. Chiosis G. Bioorg. Med. Chem. 2009, 17: 2225

Crossref PubMed Google Scholar
11 Prodromou C. Roe SM. O’Brien R. Ladbury JE. Piper PW. Pearl LH. Cell 1997, 90: 65

Crossref Google Scholar
12 Roe SM. Prodromou C. O’Brien R. Ladbury JE. Piper PW. Pearl LH. J. Med. Chem. 1999, 42: 260

Crossref Google Scholar
13 Dehner A. Furrer J. Richter K. Schuster I. Buchner J. Kessler H. ChemBioChem 2003, 4: 870

Crossref Google Scholar
14 Ali MMU. Roe SM. Vaughan CK. Meyer P. Panaretou B. Piper PW. Prodromou C. Pearl LH. Nature (London) 2006, 440: 1013

Crossref Google Scholar
15 Delmotte P. Delmotteplaquee J. Nature (London) 1953, 171: 344

Crossref PubMed Google Scholar
16 Winssinger N. Barluenga S. Chem. Commun. 2007, 22

Crossref Google Scholar
17 Barluenga S. Dakas PY. Boulifa M. Moulin E. Winssinger N. C. R. Chim. 2008, 11: 1306

Google Scholar
18 Hofmann T. Altmann KH. C. R. Chim. 2008, 11: 1318

Google Scholar
19 Lampilas M. Lett R. Tetrahedron Lett. 1992, 33: 773

Crossref Google Scholar
20 Lampilas M. Lett R. Tetrahedron Lett. 1992, 33: 777

Crossref Google Scholar
21 Tichkowsky I. Lett R. Tetrahedron Lett. 2002, 43: 3997

Crossref Google Scholar
22 Tichkowsky I. Lett R. Tetrahedron Lett. 2002, 43: 4003

Crossref Google Scholar
23 Garbaccio RM. Stachel SJ. Baeschlin DK. Danishefsky SJ. J. Am. Chem. Soc. 2001, 123: 10903

Crossref PubMed Google Scholar
24 Barluenga S. Moulin E. Lopez P. Winssinger N. Chem. Eur. J. 2005, 11: 4935

Crossref Google Scholar
25 Proisy N. Sharp SY. Boxall K. Connelly S. Roe SM. Prodromou C. Slawin AMZ. Pearl LH. Workman P. Moody CJ. Chem. Biol. 2006, 13: 1203

Crossref Google Scholar
26 Yang ZQ. Geng XD. Solit D. Pratilas CA. Rosen N. Danishefsky SJ. J. Am. Chem. Soc. 2004, 126: 7881

Crossref Google Scholar
27 Barluenga S. Lopez P. Moulin E. Winssinger N. Angew. Chem. Int. Ed. 2004, 43: 3467

Crossref Google Scholar
28 Cooper TS. Atrash B. Sheldrake P. Workman P. McDonald E. Tetrahedron Lett. 2006, 47: 2241

Crossref Google Scholar
29 Bauta WE. Lovett DP. Cantrell WR. Burke BD.
J. Org. Chem. 2003, 68: 5967

Crossref Google Scholar
30 Shair MD. Yoon TY. Mosny KK. Chou TC. Danishefsky SJ. J. Am. Chem. Soc. 1996, 118: 9509

Crossref Google Scholar
32 Shimamoto T. Chimori M. Sogawa H. Yamamoto K.
J. Am. Chem. Soc. 2005, 127: 16410

Crossref Google Scholar

31

5-Chloro-6,8-bis(methoxymethoxy)isochroman-1,3-dione (8)
Mp 96-98 ˚C. MS: m/z calcd for C₁₃H₁₃ ^³5ClNaO₇: 339.0242; found: 339.0229 [M + Na]. IR (CH₂Cl₂): ν_max = 1796, 1756, 1593 cm^-¹. ^¹H NMR (400 MHz, CDCl₃): δ = 7.18 (1 H, s, ArH), 5.48 (2 H, s, OCH₂O), 5.39 (2 H, s, OCH₂O), 4.20 (2 H, s, CH₂), 3.53 (3 H, s, OCH₃), 3.52 (3 H, s, OCH₃). ^¹³C NMR (100 MHz, acetone-d ₆): δ = 165.3 (C), 160.6 (C), 159.2 (C), 157.1 (C), 137.7 (C), 114.6 (C), 107.1 (C), 103.4 (CH), 96.3 (CH₂), 96.1 (C), 57.0 (CH₃), 56.9 (CH₃), 34.2 (CH₂). ESI-MS: m/z (%) = 341/339 (23/69) [M + Na], 327 (14), 309 (15).

33

Ethyl 2-[5-Chloro-6,8-bis(methoxymethoxy)-1-oxo-1 H -isochromen-3-yl]hept-6-enoate (13)
Mp 50-52 ˚C. MS: m/z calcd for C₂₂H₂₇ ^³5ClNaO₈: 477.1292; found: 477.1326 [M + Na]. IR (CH₂Cl₂): ν_max = 2987, 1736, 1661, 1585 cm^-¹. ^¹H NMR (400 MHz, acetone-d ₆): δ = 7.15 (1 H, s, ArH), 6.85 (1 H, s, ArH), 5.89-5.77 (1 H, m, CH=CH₂), 5.45 (2 H, s, OCH₂O), 5.34 (2 H, s, OCH₂O), 5.05-4.93 (2 H, m, CH=CH₂), 4.18 (2 H, q, J = 7.1 Hz, CO₂CH₂CH₃), 3.66 (1 H, t, J = 7.5 Hz, CHCH₂), 3.51 (3 H, s, OCH₃), 3.51 (3 H, s, OCH₃), 2.13 (2 H, dt, J = 7.1, 7.5 Hz, CH₂), 2.00-1.89 (2 H, m, CH₂), 1.49 (2 H, quin, J = 7.1, CH₂), 1.22 (2 H, q, J = 7.1 Hz, CO₂CH₂CH₃). ^¹³C NMR (100 MHz, CDCl₃): δ = 171.1 (C), 160.5 (C), 159.2 (C), 157.2 (C), 158.15 (C), 139.1 (CH), 138.6 (C), 115.3 (CH₂), 110.9 (C), 105.9 (C), 103.7 (CH), 101.2 (CH), 96.4 (CH₂), 96.0 (CH₂), 61.8 (CH₂), 56.9 (CH₃), 56.8 (CH₃), 50.5 (CH), 34.0 (CH₂), 27.2 (CH₂), 14.5 (CH₃), 1 × CH₂ unobserved. ESI-MS: m/z (%) = 475/477 (36/100) [M + Na].

34

( E )-1-Chloro-2,4-dihydroxy-7,8,11,12,13,14-hexahydro-6-oxa-16 H -benzocyclotetradecene-5,15-dione (3)
Mp 174-176 ˚C (lit.^²5 mp 168-169 ˚C). MS: m/z calcd for C₁₇H₁₉ ^³5ClNaO₅: 361.0813; found: 361.0817 [M + Na]. IR (CH₂Cl₂): ν_max = 3722, 3156, 1712, 1659, 1603 cm^-¹. ^¹H NMR (300 MHz, CDCl₃): δ = 11.80 (1 H, s, OH), 6.61 (1 H, s, ArH), 6.17 (1 H, s, OH), 5.56-5.39 (2 H, m, CH=CH), 4.44 (2 H, t, J = 5.3 Hz, CO₂CH₂), 4.29 (2 H, s, CH₂), 2.58 (2 H, t, J = 6.5 Hz, CH₂), 2.44 (2 H, dt, J = 5.3, 5.3 Hz, CH₂), 2.10 (2 H, dt, J = 6.2, 4.8 Hz, CH₂), 1.71 (2 H, quin, J = 6.2 Hz, CH₂), 1.58 (2 H, m, CH₂). ^¹³C NMR (75 MHz, CDCl₃): δ = 206.2 (C), 170.7 (C), 163.0 (C), 156.4 (C), 136.2 (CH), 134.1 (C), 126.8 (C), 114.7 (C), 107.3 (CH), 65.8 (CH₂), 46.8 (CH₂), 41.0 (CH₂), 32.2 (CH₂), 31.54 (CH₂), 25.5 (CH₂), 22.1 (CH₂). ESI-MS: m/z (%) = 363/361 (31/100) [M + Na], 341/339 (4/12).

( E )-1-Chloro-2,4-dihydroxy-7,8,11,12,13,14-hexahydro-8-methyl-6-oxa-16 H -benzocyclotetradecene-5,15-dione (17) Mp 163-164 ˚C. MS: m/z calcd for C₁₈H₂₁ ^³5ClNaO₅: 375.0970; found: 375.0959 [M + Na]. IR (CH₂Cl₂): ν_max = 3686, 3512, 1720, 1658, 1604 cm^-¹. ^¹H NMR (400 MHz, CDCl₃): δ = 11.78 (1 H, s, OH), 6.63 (1 H, s, ArH), 6.00 (1 H, br s, OH), 5.46 (1 H, dt, J = 15.6, 7.5 Hz, =CH), 5.34 (1 H, dt, J = 15.6, 7.3 Hz, =CH), 4.27 (1 H, dd, J = 10.7, 3.0 Hz, CO₂CH), 4.28 (2 H, s, CH₂), 3.99 (1 H, t, J = 10.7 Hz, CO₂CH), 2.58 (3 H, m, CH₂, CH), 2.13 (3 H, m, CH₂, CH), 1.72 (3 H, m, CH₂, CH), 1.04 (3 H, d, J = 7.0 Hz, CH₃). ^¹³C NMR (125 MHz, CDCl₃): δ = 205.7 (C), 171.8 (C), 163.8 (C), 158.9 (C), 138.3 (C), 134.3 (CH), 132.5 (CH), 115.9 (C), 107.8 (C), 103.6 (CH), 71.1 (CH₂), 47.1 (CH₂), 41.2 (CH₂), 36.7 (CH), 32.7 (CH₂), 26.6 (CH₂), 23.0 (CH₂), 17.4 (CH₃). ESI-MS: m/z (%) = 377/375 (33/100) [M + Na], 355/353 (8/23), 335/337 (31/10).

35

Crystallographic data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB21EZ, UK; fax: +44 (1223)336033; or deposit@ccdc.cam.ac.uk].